CUAMC
AVXL icon

China Universal Asset Management Company’s Anavex Life Sciences AVXL Stock Holding History

China Universal Asset Management Company’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.5K Buy
16,445
+1,886
+13% +$8.17K ﹤0.01% 454
2025
Q4 		$51.8K Sell
14,559
-497
-3% -$3.04K ﹤0.01% 448
2025
Q3 		$134K Sell
15,056
-2,091
-12% -$21.2K 0.01% 363
2025
Q2 		$158K Buy
17,147
+85
+0.5% +$726 0.01% 330
2025
Q1 		$146K Sell
17,062
-918
-5% -$8.67K 0.01% 337
2024
Q4 		$193K Buy
17,980
+1,671
+10% +$12.9K 0.02% 327
2024
Q3 		$92.6K Buy
16,309
+6,366
+64% +$36.7K 0.01% 361
2024
Q2 		$42K Sell
9,943
-5,830
-37% -$23.6K 0.01% 368
2024
Q1 		$80.3K Buy
15,773
+6,275
+66% +$35.3K 0.01% 390
2023
Q4 		$88.4K Buy
9,498
+7,395
+352% +$50.9K 0.02% 299
2023
Q3 		$13.8K Buy
2,103
+1,044
+99% +$8.31K ﹤0.01% 324
2023
Q2 		$8.61K Buy
1,059
+2
+0.2% +$17 ﹤0.01% 328
2023
Q1 		$9.06K Buy
1,057
+265
+33% +$2.65K ﹤0.01% 303
2022
Q4 		$7.33K Buy
792
+62
+8% +$662 ﹤0.01% 254
2022
Q3 		$8K Buy
+730
New +$7.7K ﹤0.01% 222

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

China Universal Asset Management Company's AVXL Position: Q1 2026 in Review

China Universal Asset Management Company increased its Anavex Life Sciences (AVXL) stake by 13% in Q1 2026, buying an estimated $8.17K and bringing the position to 16,445 shares worth $50.5K. The position accounts for ﹤0.01% of the portfolio, ranked #454.

China Universal Asset Management Company first reported a position in AVXL in Q3 2022 and has held it in 15 quarters since. The position peaked at $193K in Q4 2024. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • China Universal Asset Management Company held 16,445 shares of Anavex Life Sciences worth $50.5K as of Q1 2026.
  • China Universal Asset Management Company bought 1,886 Anavex Life Sciences shares in Q1 2026, an estimated $8.17K.
  • Anavex Life Sciences made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q1 2026, its #454 holding.
  • China Universal Asset Management Company first reported a position in Anavex Life Sciences in Q3 2022 and has held it in 15 quarters since.
  • China Universal Asset Management Company's Anavex Life Sciences position peaked at $193K in Q4 2024.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.